Computational model of chimeric antigen receptor-engineered T cells

被引：0
|
作者：
Rohrs, Jennifer [1 ]
Wang, Pin [1 ]
Finley, Stacey D. [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA USA
来源：
CANCER RESEARCH | 2015年 / 75卷 / 22期
关键词：
D O I：
10.1158/1538-7445.COMPSYSBIO-B2-33
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B2-33
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
    Cartellieri, Marc
    Bachmann, Michael
    Feldmann, Anja
    Bippes, Claudia
    Stamova, Slava
    Wehner, Rebekka
    Temme, Achim
    Schmitz, Marc
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
  • [2] Chimeric antigen receptor-engineered T cells as oncolytic virus carriers
    VanSeggelen, Heather
    Tantalo, Daniela G. M.
    Afsahi, Arya
    Hammill, Joanne A.
    Bramson, Jonathan L.
    MOLECULAR THERAPY-ONCOLYTICS, 2015, 2 : 15014
  • [3] Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer
    Victoria Hillerdal
    Magnus Essand
    BioDrugs, 2015, 29 : 75 - 89
  • [4] Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Acute Myeloid Leukemia
    Cartellieri, Marc
    Michalk, Irene
    von Bonin, Malte
    Krueger, Thomas
    Stamova, Slava
    Koristka, Stefanie
    Arndt, Claudia
    Feldmann, Anja
    Schmitz, Marc
    Wermke, Martin
    Lindemann, Dirk
    Bornhaeuser, Martin
    Ehninger, Gerhard
    Bachmann, Michael
    BLOOD, 2011, 118 (21) : 1124 - 1125
  • [5] A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
    Zhang, Erhao
    Xu, Hanmei
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10 : 1 - 11
  • [6] Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer
    Hillerdal, Victoria
    Essand, Magnus
    BIODRUGS, 2015, 29 (02) : 75 - 89
  • [7] Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
    Han, Ethan Q.
    Li, Xiu-ling
    Wang, Chun-rong
    Li, Tian-fang
    Han, Shuang-yin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [8] A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
    Erhao Zhang
    Hanmei Xu
    Journal of Hematology & Oncology, 10
  • [9] Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
    Ethan Q Han
    Xiu-ling Li
    Chun-rong Wang
    Tian-fang Li
    Shuang-yin Han
    Journal of Hematology & Oncology, 6
  • [10] The specific cytotoxicities of chimeric antigen receptor-engineered T cells on different lymphomas
    张蕊
    China Medical Abstracts (Internal Medicine), 2017, 34 (04) : 230 - 230
12345